Zobrazeno 1 - 10 of 32 pro vyhledávání: '"D van der Harst"'
1
Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones
Autor: D van der Harst, E Goulmy, JH Falkenburg, YM Kooij-Winkelaar, SA van Luxemburg- Heijs, HM Goselink, A Brand
Publikováno v: Blood. 83:1060-1066
Clinical studies indicated an enhanced antileukemic effect of allogeneic bone marrow transplantation (BMT), as compared with autologous BMT. After allogeneic HLA-identical BMT, donor-derived cytotoxic T lymphocytes (CTLs) directed at minor histocompa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fd8e1b14c4b2e56da2c069c8e6d07c8
https://doi.org/10.1182/blood.v83.4.1060.bloodjournal8341060
Zobrazit plný text záznamu
2
Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer- cell cytotoxicity [see comments]
Autor: JH Jansen, D van der Harst, GJ Wientjens, YM Kooy-Winkelaar, A Brand, R Willemze, HC Kluin-Nelemans
Publikováno v: Blood. 80:478-483
Some B-cell neoplasms, including hairy cell leukemia (HCL), lack expression of the adhesion molecule leukocyte function antigen-1 (LFA- 1/CD11a). Additionally, HCL cells express relatively low amounts of intercellular adhesion molecule-1 (ICAM-1/CD54
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c6b5711fba53ed37d818718bcca2d1a
https://doi.org/10.1182/blood.v80.2.478.bloodjournal802478
Zobrazit plný text záznamu
4
Selective outgrowth of CD45RO+ V gamma 9+/V delta 2+ T-cell receptor gamma/delta T cells early after bone marrow transplantation
Autor: Y. M. C. Kooij-Winkelaar, F. E. Zwaan, Anneke Brand, Frits Koning, D. Van Der Harst, S.A.P. van Luxemburg-Heijs
Publikováno v: Blood. 78:1875-1881
Before and after bone marrow transplantation (BMT) for hematologic malignancies, peripheral blood mononuclear cells from 10 patients were obtained. The relative and absolute numbers of CD3+ T-cell receptor yS+ (TCRyS+) cells, as defined by the reacti
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c5beb004f79241814e381e1501d32f
https://doi.org/10.1182/blood.v78.7.1875.bloodjournal7871875
Zobrazit plný text záznamu
5
Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes
Autor: Anneke Brand, W. E. Fibbe, S.A.P. van Luxemburg-Heijs, R. Willemze, L. M. Faber, J.H.F. Falkenburg, Y. M. C. Kooy-Winkelaar, J de Kroon, H. M. Goselink, D. Van Der Harst
Publikováno v: J. Exp. Med.
The Journal of Experimental Medicine
Minor histocompatibility (mH) antigens appear to play a major role in bone marrow transplantation (BMT) using HLA-identical donors. Previously, we reported the isolation of major histocompatibility complex (MHC)-restricted mH antigen-specific cytotox
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bccd7ca8fafcedc21b8ea2068327be87
https://doi.org/10.1084/jem.174.1.27
Zobrazit plný text záznamu
6
Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients
Autor: R. Willemze, N. Duinkerken, Jhf Falkenburg, W. E. Fibbe, C. R. Franks, Anneke Brand, D. Van Der Harst, M. R. Schaafsma, S Osanto
Publikováno v: British Journal of Haematology. 76:180-185
Immunotherapy with recombinant interleukin-2 (IL-2) and lymphokine-activated killer (LAK) cells has been applied to patients with metastatic cancers for its antitumour activity. In the present study we investigated the effects of in vivo administrati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78bf336520e58ba3735d1cbcbaaaf365
https://doi.org/10.1111/j.1365-2141.1990.tb07869.x
Zobrazit plný text záznamu
7
In Vivo Versus Ex Vivo Modulation of Lymphocytes; Immunotherapy for Hematological Malignancies
Autor: D. Van Der Harst, Anneke Brand, J.J. van Rood
Publikováno v: Advances in haemapheresis ISBN: 9781461367420
Since recombinant interleukin-2 (rIL-2) became available in large quantities in 1984, attention has been focussed on its potential use in the treatment of cancer patients as a fourth therapeutic modality. Clinical studies [1,2] have shown that treatm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::02b1afa37ba2d3430666f26d17db6365
https://doi.org/10.1007/978-1-4615-3904-9_20
Zobrazit plný text záznamu
8
High Levels of Circulating Hematopoietic Progenitor Cells after Continuous Infusion of High Dose Interleukin-2 in Cancer Patients
Autor: W. E. Fibbe, J.H.F. Falkenburg, Susanne Osanto, Anneke Brand, D. van der Harst, C. R. Franks, R. Willemze, N. Duinkerken, M. R. Schaafsma
Publikováno v: Advances in haemapheresis ISBN: 9781461367420
Over the past few years recombinant human interleukin-2 (IL-2), with or without infusion of in vitro generated lymphokine-activated killer (LAK) cells, has been administered to patients with disseminated cancer for its antitumor activity [1]. It has
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d63d5fb8f2250888896ff5989d0d83c8
https://doi.org/10.1007/978-1-4615-3904-9_23
Zobrazit plný text záznamu
9
Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura
Autor: D, van der Harst, D, de Jong, J, Limpens, P M, Kluin, Y, Rozier, G J, van Ommen, A, Brand
Publikováno v: Blood. 76(11)
Idiopathic thrombocytopenic purpura (ITP) may be associated with other autoimmune diseases and the development of lymphoproliferative malignancies. In Sjögren's disease, Graves' disease, and essential mixed cryoglobulinemia, which are also associate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4b7b45643b5eeab9d7dc0bd1fbf460ea
https://pubmed.ncbi.nlm.nih.gov/1701666
Zobrazit plný text záznamu
10
Lymphokine-activated killer cell functions in patients with leukemic B- lymphoproliferative diseases
Autor: J.J. van Rood, Anneke Brand, S. A. P. Van Luxemburg-Heys, D. Van Der Harst, E. M. C. Kooy-Winkelaar
Publikováno v: Blood. 74:2464-2470
Nine patients with leukemic B-lymphoproliferative diseases (B-LPD) were evaluated for development of in vitro recombinant interleukin-2 (rIL-2)- activated killer (LAK) cells. B-cell cultures were established from peripheral blood mononuclear cells (P
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dff6cc429db9cdcff14a6bee4ac5f6de
https://doi.org/10.1182/blood.v74.7.2464.2464
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje